We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ORA:ASXOrora Limited Analysis

Data as of 2026-03-15 - not real-time

A$1.89

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Orora’s share price sits at A$1.89, well below the DCF‑derived fair value of roughly A$2.89, implying a **27% upside**. The 20‑day SMA (A$2.11) and 50‑day SMA (A$2.13) sit above current levels, confirming the stock is trading at a discount to its recent averages. Technical momentum is mixed: the RSI of ~30 signals oversold conditions, while the MACD histogram remains negative, indicating lingering bearish pressure. Nevertheless, the price is perched on a clear support zone around A$1.875, offering a potential floor for a short‑term rebound.
On the fundamentals side, Orora delivered **double‑digit profit growth** in H1 2026 and revenue expanded 9.7% year‑over‑year, lifting operating margins to 11.6%. The company generates solid cash, with operating cash flow of A$0.41 bn and free cash flow near A$0.20 bn, yet carries A$0.80 bn of debt, resulting in a modest debt‑to‑equity of 29%. The dividend yield stands at an attractive **5.25%**, but the payout ratio exceeds 100% (≈104%), raising questions about dividend sustainability. Valuation multiples are modest – a forward P/E of 12.3 and a price‑to‑book of 0.84 – positioning the stock in the **value‑blend** space.
Risk metrics show low systematic risk (beta ≈ 0.34) but heightened price volatility (~40% 30‑day) and a decreasing volume trend, suggesting liquidity pressure. The packaging sector faces medium regulatory and geographic exposure, especially given operations in Australia, New Zealand and the United States. Given the sizable upside, strong cash generation and a supportive dividend, we view the stock as **undervalued** with a bias toward growth. Consequently, we recommend buying across horizons while monitoring dividend coverage and liquidity constraints.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • RSI near 30 indicating oversold condition
  • Support level at A$1.875 provides price floor
  • Attractive dividend yield of 5.25% despite coverage concerns

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF implied upside of ~27% suggests undervaluation
  • Revenue growth of 9.7% and improving operating margins
  • Strong cash flow generation supports reinvestment

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Blend of value and growth metrics with low beta
  • Sustainable cash generation offsets moderate debt
  • Long‑term dividend income potential if payout ratio improves

Key Metrics & Analysis

Financial Health

Revenue Growth9.70%
Profit Margin5.68%
P/E Ratio18.9
ROE4.35%
ROA3.62%
Debt/Equity28.95
P/B Ratio0.8
Op. Cash FlowA$412.5M
Free Cash FlowA$199.3M

Technical Analysis

TrendNeutral
RSI30.0
SupportA$1.88
ResistanceA$2.35
MA 20A$2.11
MA 50A$2.13
MA 200A$2.10
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueA$2.89
Target PriceA$2.40
Upside/Downside27.11%
GradeUndervalued
TypeBlend
Dividend Yield5.25%

Risk Assessment

Beta0.34
Volatility39.64%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.